Aqr Capital Management LLC Nuvalent, Inc. Transaction History
Aqr Capital Management LLC
- $95.2 Billion
- Q1 2025
A detailed history of Aqr Capital Management LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 9,874 shares of NUVL stock, worth $756,447. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,874
Previous 5,993
64.76%
Holding current value
$756,447
Previous $469,000
49.25%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NUVL
# of Institutions
226Shares Held
61MCall Options Held
334KPut Options Held
199K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.38 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$404 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$232 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$142 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.29B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...